CBD Life Sciences (CBD Life Sciences) Debt-to-Equity : 0.00 (As of Sep. 2015)

View and export this data going back to 2009. Start your Free Trial

What is CBD Life Sciences Debt-to-Equity?

CBD Life Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.00 Mil. CBD Life Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.00 Mil. CBD Life Sciences's Total Stockholders Equity for the quarter that ended in Sep. 2015 was $0.21 Mil. CBD Life Sciences's debt to equity for the quarter that ended in Sep. 2015 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for CBD Life Sciences's Debt-to-Equity or its related term are showing as below:

CBDL's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

CBD Life Sciences Debt-to-Equity Historical Data

The historical data trend for CBD Life Sciences's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CBD Life Sciences Debt-to-Equity Chart

CBD Life Sciences Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Debt-to-Equity

CBD Life Sciences Quarterly Data
	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Debt-to-Equity	Get a 7-Day Free Trial											-	-	-	-	-

Competitive Comparison of CBD Life Sciences's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, CBD Life Sciences's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CBD Life Sciences's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CBD Life Sciences's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where CBD Life Sciences's Debt-to-Equity falls into.

CBD Life Sciences Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

CBD Life Sciences's Debt to Equity Ratio for the fiscal year that ended in Dec. 2014 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	-0.013
	=	0.00

CBD Life Sciences's Debt to Equity Ratio for the quarter that ended in Sep. 2015 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0.209
	=	0.00

CBD Life Sciences (OTCPK:CBDL) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

CBD Life Sciences Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of CBD Life Sciences's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CBD Life Sciences (CBD Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CBD Life Sciences Inc (OTCPK:CBDL) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

10853 N. Frank Llyod Wright Boulevard, Suite 108, Scottsdale, AZ, USA, 85259

Website

https://lbcbioscienceinc.com

CBD Life Sciences Inc is developing and marketing a line of cannabidiol based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products. The company is also in the process of developing an anti-aging skin product line.